Rethinking Lead Optimization:
Adopting New Synthetic Biology Tools to Accelerate Development Timelines
White paper: Read how advances in synthetic biology automation are enabling researchers to to streamline antibody discovery and optimization workflows.
In this white paper, you’ll learn how:
- Antibody development programs can overcome process bottlenecks and realize substantial process optimization gains by leveraging continuing advances in synthetic biology automation.
- Comprehensive automated workflow solutions enable antibody therapeutic scientists to leverage synthetic biology for both lead discovery and optimization, at a throughput, speed and scale that keeps pace with the current demands of development timelines.
Telesis Bio’s BioXp® automation platform streamlines screening and optimization workflows of antibody candidates by enabling high-throughput synthesis and cloning as well as generation of antibody variant libraries overnight, and at the push of a button.